Showing results (251-260 of 302) with videos related to

Sort By:
Pageof 31
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 17, 2022
Breakthrough COVID-19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipientsIlies Benotmane, Aurélie Velay, Gabriela Gautier-Vargas, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 15, 2026
Association of Complement Genetics with Outcomes in IgA NephropathyAnna Duval, Nicolas Maillard, Martin Morin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 7, 2023
Haemoglobin trajectories in chronic kidney disease and risk of major adverse cardiovascular eventsLisa Le Gall, Jérôme Harambat, Christian Combe, et al.
Blood Advances|April 11, 2022
A gain-of-function variant in the Wiskott-Aldrich syndrome gene is associated with a MYH9-related disease-like syndromeDavid Marx, Arnaud Dupuis, Anita Eckly, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 17, 2023
Tacrolimus Exposure Before and After a Switch From Twice-Daily Immediate-Release to Once-Daily Prolonged Release Tacrolimus: The ENVARSWITCH StudyCaroline Monchaud, Jean-Baptiste Woillard, Sabrina Crépin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 15, 2010
Renal biopsy practice in France: results of a nationwide studyGuillaume Bollée, Frank Martinez, Bruno Moulin, et al.
Kidney International|March 30, 2012
Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathiesAude Servais, Laure-Hélène Noël, Lubka T Roumenina, et al.
British Journal of Haematology|August 8, 2006
Long-term survival in post-transplant lymphoproliferative disorders with a dose-adjusted ACVBP regimenCécile Fohrer, Sophie Caillard, Argyro Koumarianou, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 15, 2012
Late clinical outcomes after implantation of drug-eluting stents coated with biodegradable polymers: 3-year follow-up of the PAINT randomised trialPedro A Lemos, Bruno Moulin, Marco A Perin, et al.
Critical Care Medicine|September 20, 2011
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference CenterAntoine Froissart, Marc Buffet, Agnès Veyradier, et al.
Pageof 31